Skip to content
PLTR$173.00-11.11(-6.03%)Palantir: 3 Key Takeaways for Long-Term Investors12:44:59 AM ETGS$901.00+4.17(+0.47%)Goldman Sachs raises 2027 Europe gas price forecasts on MidEast supply, winter risks12:09:21 AM ETGOOGL$280.40-0.85(-0.30%)ANALYSIS -AI-related debt binge may pressure European bond markets12:00:01 AM ETMS$185.73+1.43(+0.78%)BREAKINGVIEWS-Morgan Stanley is a dubious saviour for UBS12:00:00 AM ETCRM$226.00-3.17(-1.38%)Massive News for Salesforce Stock Investors11:45:02 PM ETARM$197.01-8.96(-4.35%)Why Arm Holdings Stock Lost 29% Last Month11:18:59 PM ETORCL$119.50-11.17(-8.55%)UPDATE 6-Oracle taps investors for $20 billion to finance AI expansion10:58:17 PM ETSKHY$148.53-0.68(-0.46%)Samsung and SK Hynix stocks plunge as a $20 billion AI shock rattles markets10:39:42 PM ETC$123.30+0.46(+0.38%)Japanese, Korean, Taiwanese firms' US investment set to keep climbing: Citi10:38:12 PM ETKO$95.96+1.88(+2.00%)Coca-Cola Is Exercising its Pricing Power as Inflation Persists10:35:02 PM ETGOOG$279.21+0.99(+0.36%)Google takes Dreambeans to India in bid to bring AI-generated personal stories to the masses10:30:00 PM ETORCL$119.50-11.17(-8.55%)BRIEF-Oracle Prices $20 Billion Of Common Stock And Senior Notes10:16:41 PM ETORCL$119.50-11.17(-8.55%)Oracle Announces Pricing of $20 Billion of Common Stock and Senior Notes10:10:08 PM ETPLTR$173.00-11.11(-6.03%)Palantir Technologies Inc. (PLTR) Q3 2026 Earnings Call Transcript10:08:30 PM ETIUSG$181.79-1.75(-0.95%)IUSG: Hyperscaler Sell-Off Is Overblown - Buy The Dip9:19:55 PM ETAAPL$328.81-15.82(-4.59%)Apple Forecasts Slower Services Growth as AI Costs Rise9:09:51 PM ETCRDO$140.88-10.11(-6.70%)Credo vs. Sandisk: Which Stock Is the Better Buy for 2027?9:00:02 PM ETAAPL$328.81-15.82(-4.59%)Apple may try to increase revenue by doing8:49:52 PM ETCVX$228.21-7.75(-3.29%)Chevron & Exxon Mobil Stocks Retreat From 52-Week Highs: Buy the Dip?8:21:06 PM ETAAPL$328.81-15.82(-4.59%)Apple Q4 Earnings Call Highlights8:14:45 PM ETPLTR$173.00-11.11(-6.03%)What Palantir Technologies (PLTR) Said on Its Q3 Earnings Call8:14:22 PM ETACN$261.99+2.70(+1.05%)Top 25 Attractive Dividend Stocks For November 20268:10:22 PM ETPLTR$173.00-11.11(-6.03%)Here's why Palantir's stock is down despite a ‘bombastic' quarter7:59:00 PM ETAAPL$328.81-15.82(-4.59%)Apple's iPhone business is booming. Here's why the stock is falling anyway.7:52:00 PM ET

DSS · AMEX

DSS, Inc.

$0.51 -0.01 (-1.76%)

Company overview

DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focus on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for airborne infectious diseases comprising tuberculosis and influenza.

Sector
Consumer Cyclical
Industry
Packaging & Containers
Exchange
AMEX
Market cap
$5.1M
Employees
100
Headquarters
West Henrietta, NY
CEO
Jason T. Grady
Listed
April 8, 1994
P/E
-0.19
Dividend yield
0.00%

Company financials

Revenue
$20.1M
Gross profit
-$3.1M
Operating income
-$16.2M
EBITDA
-$25.3M
Net income
-$25M
EPS
-$2.71
Total assets
$71.3M
Total debt
$36.9M
Gross margin
-15.58%
Net margin
-124.24%
Earnings yield
-531.37%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

0.330.550.770.991.21
DSS 1D AMEX O0.51H0.52L0.50C0.50-0.01 (-1.76%)Vol1.78K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
DSSDSS, Inc. Press release DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination ACCESS Newswire
DSSDSS, Inc. Press release DSS, Inc. Announces Form F-4 Filing in Connection with GlobeNewswire
DSSDSS, Inc. Press release DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations GlobeNewswire
DSSDSS, Inc. Stock news DSS Shares Crash After Soaring. What the New Offering Means for Investors GuruFocus
DSSDSS, Inc. Stock news DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering GlobeNewswire
DSSDSS, Inc. Press release DSS, Inc. Announces Launch of Proposed Public Offering GlobeNewswire
DSSDSS, Inc. Press release DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing GlobeNewswire
DSSDSS, Inc. Stock news DSS, Inc. Letter to Shareholders GlobeNewswire
DSSDSS, Inc. Press release DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering GlobeNewswire
DSSDSS, Inc. Press release DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering GlobeNewswire
DSSDSS, Inc. Press release DSS, Inc. Announces Launch of Proposed Public Offering GlobeNewswire
FAQ

Questions about DSS, Inc.

What does DSS, Inc. do?
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focus on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for airborne infectious diseases comprising tuberculosis and influenza.
What is DSS's market cap?
DSS, Inc. (DSS) is a listed stock with a live quote. The latest market cap on this page is $5.1M.
Where is DSS, Inc. headquartered?
DSS, Inc. is headquartered in West Henrietta, NY.
How do I get DSS news from the API?
Call GET /v1/news?tickers=DSS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does DSS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for DSS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the DSS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.